Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 421 (OTC: $CSUI)
(CSE: $OILS.C) (TSX: $VLNS.TO) (OTCQX: $CANN)
Delta, Kelowna, BC, June 1, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s
podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research &
development company licensed under Swiss Cannabis and tobacco regulations to
cultivate and sell cannabis. The Company's facilities for producing cannabis
are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
In
today’s podcast we will be looking at a few public company announcements.
Nextleaf Solutions
Ltd.
(CSE:
OILS) (OTCQB:
OILFF), Canada's most innovative cannabis extractor, announced
today that it has been issued more patents in North America,
Asia, and Europe. These additional patents were awarded in jurisdictions
including, but not limited to: the United States; Spain; Portugal; Poland;
Malta; Ireland; Denmark; and, Cambodia. These latest issued patents pertain to
the Company's unique method of extracting and separating cannabinoids and
terpenes.
These
patents extend the Company's existing patent portfolio to protect methodologies
relating to the removal of fats and waxes during the extraction and
purification process, achieving more efficient throughput rates and a higher
quality distillate. Less refined cannabis extracts contain chlorophyll, fats,
and other impurities that result in undesirable flavours and aromas.
With
the latest patent issues, OILS has advanced its intellectual property ("IP") stack to over 35 issued
patents, and 65 pending patents, for the industrial-scale extraction, and
distillation of cannabinoids. With a 100% pending application to issued patent
success rate, the Company has developed defendable IP around the most efficient
methods for producing distilled THC and CBD at scale within a regulated
environment.
OILS
considers European IP protection to be particularly important due to the
increasing demand for medical cannabis and CBD products in these rapidly
legalizing markets. Prohibition Partners projects the legal European
cannabinoid market will be worth more than US$39 billion by 2024, compared to
US$37 billion for the more mature North American market by the same time.
The
Company's patent portfolio includes protection around the methodologies and
technology necessary to efficiently process dried cannabis and hemp biomass
into high-purity THC and CBD oils that are used in the manufacturing of
cannabinoid formulations and products.
"We
expect these patents will have a major impact on the production and sale of
standardized cannabinoid-based products in Europe over the twenty year life of
the patents," said Paul Pedersen, CEO. "These are jurisdictions that
collectively manufacture and export over 70% of all drugs and medicines
consumed globally, making European IP protection very important to our
long-term global strategy", continued Pedersen.
Valens GroWorks
Corp. (TSX:
VLNS) (OTCQX:
VLNCF), a global
leader in the end-to-end development and manufacturing of innovative,
cannabinoid-based products, today
announced it has entered into a syndicated credit facility with
Canadian Imperial Bank of Commerce as Co-Lead Arranger and Administrative
Agent, and ATB Financial as Co-Lead Arranger. Under the terms of the credit
facility, the Lenders will provide The Valens Company up to C$40 million of
secured debt financing.
The
Credit Facility consists of a C$20 million secured term loan and a C$20 million
secured revolving loan, with an accordion feature that could allow The Valens
Company to increase the aggregate commitments by up to an additional C$10
million. The Credit Facility has a three-year term and is secured by a first
ranking charge over substantially all the Company's assets.
Proceeds
from the Credit Facility will further strengthen the Company's balance sheet,
allowing for the continued expansion of its operations and execution of its
corporate strategy, including gaining access to new domestic and global
opportunities to increase shareholder value.
"Although
we are already well capitalized, the Credit Facility increases our financial
flexibility and brings down our overall weighted average cost of capital. With
our enhanced balance sheet, we are well positioned to continue to expand our
innovative product portfolio, build out our custom manufacturing platform, be
opportunistic in a consolidating market and maximize capital allocation to
generate the highest return on invested capital for our shareholders,"
said Tyler Robson, CEO of The Valens Company.
General Cannabis
Corp. (OTCQX:
CANN), the leading publicly traded Colorado cannabis
company, announced
today that it has reached an agreement that will bring up to
$3 million in strategic growth capital to the company. The investment will be funded by Hershey
Strategic Capital LP and Shore Ventures III, LP, entities led by managing
member Adam Hershey.
The
investment is another important step in General Cannabis’ Colorado-based
expansion strategy. Over the last two
months, General Cannabis became only the second publicly traded cannabis
company approved by the State of Colorado’s Marijuana Enforcement Division (the
“MED”) to acquire licensed cultivation, manufacturing and retail cannabis
operations throughout the state of Colorado.
Shortly thereafter, the company closed its acquisition of Boulder,
Colorado-based SevenFive Farm, a 17,000 square feet light deprivation
greenhouse. Last week, General Cannabis
was conditionally approved by the MED, subject to local approval, to close its
next planned acquisition—Pueblo, Colorado-based Cannasseur, a vertically
integrated company that commenced operations in 2013 and operates a
recreational retail dispensary, a 12,000 square foot light deprivation
greenhouse and a manufacturing facility that produces Dabtek, a product line of
infused concentrates. General Cannabis’
Next Big Crop division continues to operate as an industry leader in the
application, design, buildout and operation of cultivation facilities, having
worked with over 100 cultivation facilities across the country.
Steve
Gutterman, CEO of General Cannabis, said: “This significant capital infusion is
a powerful statement about our team, our strategy, the market opportunity and
our ability to build shareholder value. We are excited to work with Adam
Hershey to leverage the extraordinary market opportunity and competitive
advantage offered by MED approval and build on the foundation of our SevenFive
Farm acquisition and our planned closing of our Cannasseur agreement. Even in
the midst of the tremendous headwinds facing our country and the economy, we
believe we are as well-positioned as any company in the space to succeed, and
this investment is a further demonstration of that. I want to acknowledge the
extraordinary group of executives and professionals in our company, including
everyone in our NBC division, our finance, accounting and M&A teams and our
new colleagues at SevenFive Farm, whose hard work and focus have put General
Cannabis in this position to succeed.”
Said
Adam Hershey, “As an investor in the cannabis space, we evaluate many potential
deals. General Cannabis, which has a
great team and a clear growth path, stood out from the rest. We couldn’t be more excited to become
investors.”
Once
again, today’s podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a
research & development company licensed under Swiss Cannabis and tobacco
regulations to cultivate and sell cannabis. The Company's facilities for
producing cannabis are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: CSUI is a paid monthly cannabis news and social
media client More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
